Open AccessNAD + homeostasis in human health and disease
Author(s) -
ZapataPérez Rubén,
Wanders Ronald J A,
Karnebeek Clara D M,
Houtkooper Riekelt H
Publication year - 2021
Publication title -
embo molecular medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.923
H-Index - 107
eISSN - 1757-4684
pISSN - 1757-4676
DOI - 10.15252/emmm.202113943
Subject(s) - nad+ kinase , nicotinamide adenine dinucleotide , cofactor , biology , biochemistry , homeostasis , enzyme , endocrinology
Depletion of nicotinamide adenine dinucleotide (NAD + ), a central redox cofactor and the substrate of key metabolic enzymes, is the causative factor of a number of inherited and acquired diseases in humans. Primary deficiencies of NAD + homeostasis are the result of impaired biosynthesis, while secondary deficiencies can arise due to other factors affecting NAD + homeostasis, such as increased NAD + consumption or dietary deficiency of its vitamin B3 precursors. NAD + depletion can manifest in a wide variety of pathological phenotypes, ranging from rare inherited defects, characterized by congenital malformations, retinal degeneration, and/or encephalopathy, to more common multifactorial, often age‐related, diseases. Here, we discuss NAD + biochemistry and metabolism and provide an overview of the etiology and pathological consequences of alterations of the NAD + metabolism in humans. Finally, we discuss the state of the art of the potential therapeutic implications of NAD + repletion for boosting health as well as treating rare and common diseases, and the possibilities to achieve this by means of the different NAD + ‐enhancing agents.